Skip to main content
  • 6-Electrode RDN Significantly Lowers Office Systolic BP at 6 Months vs. Sham Procedure – Randomized Trial

    A novel, six-electrode renal denervation (RDN) device showed significantly reduced office systolic blood pressure at 6 months post-procedure in patients with uncontrolled hypertension despite taking antihypertensive medication as compared to patients who underwent a sham procedure, according to new randomized trial results.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details